|
Volumn 187, Issue 3, 2012, Pages 912-
|
Re: Contemporary experience with ketoconazole in patients with metastatic castration-resistant prostate cancer: Clinical factors associated with psa response and disease progression
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABIRATERONE ACETATE;
ANTIANDROGEN;
GONADORELIN AGONIST;
KETOCONAZOLE;
PROSTATE SPECIFIC ANTIGEN;
ABDOMINAL DISCOMFORT;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER HORMONE THERAPY;
CANCER LOCALIZATION;
CANCER PATIENT;
CASTRATION RESISTANT PROSTATE CANCER;
DIZZINESS;
DRUG COST;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
DRUG WITHDRAWAL;
FATIGUE;
FOLLOW UP;
HUMAN;
METASTATIC CASTRATION RESISTANT PROSTATE CANCER;
NAUSEA;
NOTE;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RETROSPECTIVE STUDY;
|
EID: 84856852718
PISSN: 00225347
EISSN: 15273792
Source Type: Journal
DOI: 10.1016/j.juro.2011.11.069 Document Type: Note |
Times cited : (1)
|
References (0)
|